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Objective: The purpose of this study was to evaluate an algorithm to maximize native arteriovenous fistulae (AVF) for
hemodialysis access.
Methods: The prospective study design was set in an academic, tertiary care medical center. The study subjects were adults
referred for permanent, upper extremity hemodialysis access between April 1999 and May 2001. Intervention included
Doppler arterial pressures/waveforms and duplex imaging of the basilic, cephalic, and central veins. The optimal
configuration for an AVF was determined (criteria: vein >3 mm, no arterial inflow stenosis, no venous outflow stenosis)
on the basis of the noninvasive studies, and unilateral arteriography/venography was performed to confirm the choice.
Permanent hemodialysis access was created on the basis of the imaging studies, and remedial imaging/intervention was
performed if the AVF failed to mature. Outcome measures included impact of the noninvasive/invasive imaging,
perioperative morbidity/mortality, incidence of successful AVF, time to cannulation, and predictors of AVF failure with
multivariate analysis.
Results: A total of 139 new access procedures was performed in 131 patients (age, 53  16 years; male, 51%; white, 60%;
diabetic, 49%; actively undergoing dialysis, 50%; prior permanent access, 26%). The noninvasive imaging showed that 83%
of the patients were candidates for AVF, with a mean of 2.7 2.1 possible configurations. Invasive imaging was abnormal
in 38% (forearm arterial disease > central vein stenosis > inflow stenosis) and impacted the operative plan in 19%. AVF
were performed in 90% of the cases (brachiobasilic > brachiocephalic > radiocephalic > radiobasilic), with prosthetic
AVF performed primarily because of inadequate veins. Among the patients who underwent AVF, the 30-day mortality
rate was 1%, the complication rate was 20% (wound, 10%; hand ischemia, 8%), and 24% needed a remedial procedure. The
AVF matured sufficiently for cannulation in 84% of those with sufficient follow-up and was suitable for cannulation by
3.4  1.8 months. On the basis of an intention to treat approach, an AVF sufficient for cannulation developed in 71% of
the 139 cases referred for access. The multivariate analysis predicted that female gender (odds ratio, 9.7; 95% CI, 2.2 to
43.5) and the radiocephalic configuration (odds ratio, 4.6; 95% CI, 1.1 to 18.6) were both independent predictors of
failure of the fistula to mature.
Conclusion: With the aggressive algorithm, the construction of native AVF is possible in the overwhelming majority of
patients presenting for new hemodialysis access. (J Vasc Surg 2002;36:452-9.)
The National Kidney Foundation Dialysis Outcome
Quality Iniative Clinical Practice (DOQI)1 guidelines ad-
vocate increasing the placement of native arteriovenous
fistulae across the country, with a target goal of 50% for all
new permanent hemodialysis accesses. The current stan-
dard of care across the country, however, falls far short of
this target. Indeed, The Dartmouth Atlas of Vascular
Health Care2 reported that only 17% of all initial perma-
nent hemodialysis access procedures among Medicare pa-
tients from 1996 to 1997 were native arteriovenous fistu-
lae, with a range from 3% to 73% by hospital referral region.
The explanation for the relatively low utilization of native
arteroivenous fistulae remains unknown but is likely multi-
factorial. The potential contributing factors include the
relative ease of implanting prosthetic fistulae, obligatory
time for native fistulae maturation, ease of cannulating
prosthetic fistulae, differences in reimbursement, uncer-
tainty about the puported superiority of native arterio-
venous fistulae, and feasibility. This study was designed to
prospectively validate an algorithm to maximize the use of
native arteriovenous fistulae and to assess the value of both
preoperative noninvasive and invasive imaging.
METHODS
Experimental design. Adult patients referred to the
Vascular Surgery Service at the University of Florida Col-
lege of Medicine for new, permanent, upper extremity
hemodialysis access between April 1999 and May 2001
were prospectively enrolled in the study (Fig). Patients
underwent upper extremity arterial and venous imaging in
the noninvasive vascular laboratory, and the optimal con-
figuration for a native arteriovenous fistula was selected.
From the Departments of Surgerya and Medicine,b University of Florida
College of Medicine; and the Department of Surgery, Malcom Randall
Veterans Affairs Medical Center.c
Competition of interest: nil.
Presented at the Twenty-Sixth Annual Meeting of The Southern Association
for Vascular Surgery, Miami Beach, Fla, Jan 16-19, 2002.
Reprints not available from author.
Copyright © 2002 by The Society for Vascular Surgery and The American
Association for Vascular Surgery.
0741-5214/2002/$35.00  0 24/6/127342
doi:10.1067/mva.2002.127342
452
Patients subsequently underwent venography/arteriogra-
phy in the ipsilateral extremity, and the impact of the
invasive imaging was analyzed. Permanent hemodialysis
access then was created on the basis of the results of the
preoperative imaging studies with standard surgical tech-
nique. Patients who underwent native arteriovenous fistu-
lae were followed until either maturation or failure, and
remedial invasive imaging/interventions were performed
as necessary. The subset of patients who were actively
undergoing dialysis was maintained before fistula matura-
tion with tunneled, temporary catheters preferentially in-
serted through the internal jugular vein.
Patients. A total of 139 access procedures was per-
formed in 131 patients during the study. Six additional
patients were referred for permanent access but were ex-
cluded from the study because of known, bilateral upper
extremity central vein occlusions. The mean patient age at
the time of procedure was 53 16 years, and most patients
were both male (51%) and white (60%). Almost one half of
the patients were diabetic (49%), and almost a quarter
(24%) were obese (120% ideal body weight). One half of
the patients were undergoing dialysis at the time of the
access procedure (mean, 1.0  3.6 years; range, 0 to 24
years), and 94% of these were undergoing dialysis through
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temporary, tunneled catheters. Approximately one quarter
of the patients (26%) had previously undergone some type
of permanent hemodialysis procedure (mean, 0.6  1.9
procedures; range, 0 to 17 procedures).
Noninvasive vascular laboratory testing. Segmental
pressures and velocity waveforms were obtained in the
brachial, radial, and ulnar arteries with appropriately sized
pressure cuffs and a continuous wave Doppler scan inter-
faced to an analogue recording device (IMEX). A distal
pressure waveform was obtained on a single digit in each
hand with photoplethysmography, and the patency of the
palmar arch and the dominance of the radial or ulnar
arteries were assessed with the same system. The diameters
of both the radial and the brachial arteries at the wrist and
immediately above the antecubital fossa, respectively, were
determined with duplex ultrasound scan imaging (Ad-
vanced Technology Laboratory). The cephalic and basilic
veins were imaged from the wrist to the axilla, and their
patency and diameters were determined with standard du-
plex scan techniques. The room was warmed, and hot
compresses were applied to the extremity or proximal tour-
niquets were inflated as necessary to facilitate venodilation
and assessment of the maximum vein diameter.3 In addi-
tion, the axillary and subclavian veins were interrogated for
the presence of thrombus with duplex ultrasound.
Invasive imaging. Preoperative venograms were ob-
tained in the extremity deemed most suitable for arterio-
venous fistula on the basis of the noninvasive imaging. A
superficial vein in the hand or forearm was cannulated, and
the venous runoff from the superficial veins to the superior
vena cava was imaged with digital subtraction angiography
(Toshiba). Complete visualization of the arterial tree from
the aortic arch to the digits in the same extremity was then
obtained if no central vein stenoses were detected on the
venogram. This was accomplished with contrast injection
into the aortic arch and subclavian artery (selective) with a
retrograde femoral approach. A similar approach was used
on the contralateral extremity if a significant (50% diam-
eter reduction) central vein stenosis was found. Iodinated
contrast was used for both the venogram and the arterio-
gram if patients were currently undergoing dialysis, and
carbon dioxide (venogram)4 and gadolinium (arteriogram)
were used if patients had not yet started hemodialysis.
Remedial invasive imaging in the postoperative period en-
tailed either a fistulogram alone or an arteriogram/fistulo-
gram/venogram, depending on the clinical suspicion. Fis-
tulograms were obtained with cannulation of the proximal
aspect of the fistula when a stenosis in the mid/distal
portion of the fistula or in the central veins was suspected. A
complete arteriogram/fistulogram/venogram was ob-
tained with the retrograde femoral artery approach when an
arterial inflow or anastomotic problem was suspected. Bal-
loon angioplasties of significant stenoses in the central veins
or fistula itself were performed at the time of the remedial
imaging as necessary, although endovascular treatment of
the latter was reserved for focal stenoses.
Fistula configuration and selection criteria. The fol-
lowing four configurations of native arteriovenous fistulae
were used: radiocephalic, radiobasilic, brachiocephalic, and
brachiobasilic. The choice was made on the basis of the
results of the noninvasive/invasive imaging. When several
choices were possible, the one considered most likely to be
successful was selected, although attempts were made to
use the nondominant extremity over the dominant extrem-
ity, the forearm over the arm, radiocephalic over radiobasi-
lic, and brachiocephalic over brachiobasilic when the
choices were equivalent. The specific criteria used to deter-
mine whether a vein or artery was suitable for a fistula are
shown in Table I. Once the specific site for fistula configu-
ration was chosen, the vein to be used was mapped with
duplex ultrasound scan to facilitate dissection. If there was
concern about the adequacy or the length of the identified
vein, additional veins usable for alternative or composite
configuration were also marked.
Operative technique. Both regional and general en-
dotracheal anesthetic techniques were used, with the choice
contingent on the preference of the operative team, the site
of the planned fistula (regional, forearm; general, arm), and
the potential to harvest vein from the other extremities for
composite configuration. When preoperative venous du-
plex imaging identified no suitable vein, the peripheral
veins were reexamined intraoperatively with duplex ultra-
sound scan after induction of anesthesia or the veins were
dissected and examined directly. Arteriovenous fistulae
with either prosthetic material (6-mm polytetrafluoroeth-
ylene) or superficial femoral vein5 were performed when
the veins were inadequate, although the intraoperative
criteria for vein diameter were slightly more liberal than the
strict preoperative criteria, and veins in the 2.7-mm to
2.9-mm range were used. Patients routinely underwent
anticoagulation therapy with heparin immediately before
vessel occlusion, and the anastomoses were performed with
loupe magnification with either 5-0 or 6-0 suture. The
basilic vein was dissected from its anatomic bed and trans-
posed in the immediate subcutaneous plane for the radio-
basilic6 and brachiobasilic7 configurations. The access and
peripheral pulses were interrogated with both physical ex-
amination and continuous wave Doppler on completion of
the procedure. Flow through the fistula was measured with
an electromagnetic flow meter (Stratham). Composite vein
Table I. Criteria to determine suitability of artery and
vein for native fistula
Vein
Diameter 3 mm without evidence of significant stenosis.
Suitable segment from wrist to antecubital fossa (forearm
fistula) or antecubital fossa to axilla (arm fistula).
Absence of significant central vein stenosis in ipsilateral
extremity.
Artery
Diameter 2 mm.
Absence of hemodynamically significant inflow stenosis.*
Nondominant radial artery for wrist fistulae.
*15-mm Hg pressure gradient between brachial arteries for proposed arm
fistulae or between ipsilateral brachial and radial arteries for proposed
forearm fistulae.
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fistulae were constructed with either the saphenous or the
basilic vein when the primary vein was of insufficient length.
Several different types of remedial procedures were per-
formed for treatment of either a complication or a failure of
the fistula to mature including vein patch angioplasty and
revision of the proximal anastomosis. Symptomatic hand
ischemia was treated with either ligation of the fistula,
correction of the arterial inflow stenosis, or the distal revas-
cularization/interval ligation (DRIL) procedure.8 The
DRIL procedures were configured with the proximal anas-
tomosis of the bypass 7 cm or more above the fistula
anastomosis and the distal anastomosis and ligation imme-
diately distal to the fistula anastomosis.
Follow-up and outcome. Most patients were admit-
ted to the hospital as “short stays” or “23-hour admissions”
after the procedure for observation of both wounds and
hand (adequacy of distal perfusion). Patients who under-
went native arteriovenous fistulae were seen in the outpa-
tient clinic less than 2 weeks after surgery and at monthly
intervals thereafter until the fistula was sufficiently mature
for cannulation. No specific hand or arm exercises were
prescribed to facilitate fistula maturation. Fistulae that were
not progressing sufficiently by 2 to 3 months and those
with presumed stenoses on the basis of the absence of a
thrill underwent remedial invasive imaging and interven-
tion as necessary. Fistulae were deemed “successes” if they
were cannulated for dialysis on six occasions9 for those
patients who were actively undergoing dialysis or if they
were sufficiently dilated and ready for cannulation for those
patients who were not actively undergoing dialysis. Criteria
for cannulation included an estimated vein diameter of 6
mm or more and a suitable vein wall thickness, although no
objective criteria were used for the latter.
Analyses and statistics. The impact of the noninva-
sive and invasive imaging was analyzed for all patients
enrolled in the study. The analysis of the perioperative
outcome was restricted to those patients who underwent
native arteriovenous fistulae. Fistulae that had not dilated
significantly for cannulation despite remedial interventions
were declared “failures” at 6 months even if they were still
patent. Differences between patients groups were com-
pared with a Student t test for the continuous variables and
2 analysis for the categoric variables.Multivariate analyses
incorporating demographics (age, gender, race), comor-
bidities (HIV, diabetes, obesity), dialysis history (prior
permanent hemodialysis access, currently undergoing dial-
ysis), operative procedure (radiocephalic, radiobasilic, bra-
chiobasilic, brachiocephalic), vein diameter (3 mm, 3 to 4
mm, 4 mm), and flow measurements (180 mL/min,
180 to 300 mL/min, 300 mL/min) were performed
with logistic regression and backward elimination in SAS
(SAS Institute) to predict fistula failure. Because intraoper-
ative flow measurements were not available for all patients,
multivariate analyses were performed on the subsets of
patients with data available for all other variables both
including (n  76) and excluding (n  93) the flow
measurements. All values are reported as the mean value
the standard deviation, and a P value of less than .05 was
accepted as significant. The Institutional Review Board at
the University of Florida approved the study.
RESULTS
The preoperative noninvasive imaging showed that
83% (115/139) of the patients for permanent hemodialysis
access were candidates for native arteriovenous fistulae with
the defined criteria (Table I). A mean of almost three
possible configurations (2.7  2.1) were identified per
patient among the eight total (bilateral—radiocephalic,
radiobasilic, brachiocephalic, brachiobasilic). Seventy-eight
percent of the patients were candidates for a brachiobasilic
fistula, 48% were candidates for a brachiocephalic fistula,
and 29% were candidates for radiocephalic and radiobasilic
fistulae. The mean number of possible fistula configurations
per patient was lower for those patients with prior, perma-
nent hemodialysis accesses (2.1 2.0 versus 2.9 2.1; P
.04), although the percentage of patients that were candi-
dates for native arteriovenous fistula was similar (75% versus
85%; P  not significant).
Ninety-four percent (130/139) of the patients under-
went preoperative invasive imaging (arteriogram, 81%;
venogram, 94%; both, 81%) in the extremity selected for
the arteriovenous fistula on the basis of the noninvasive
studies. Invasive imaging was not performed in the remain-
ing cases for a variety of reasons, including patient refusal,
surgeon choice, and unavailability of the imaging suite/
personnel. Some type of abnormal finding was seen in 38%
of the patients and included significant forearm arterial
occlusive disease (50% diameter reduction) in 30%, sig-
nificant arterial occlusive disease proximal to the brachial
artery at the antecubital fossa in 5%, and significant central
vein stenoses in 8%. These findings changed the operative
plan generated on the basis of the noninvasive studies in
19% of the cases. The radial artery was deemed inadequate
for the fistula anastomosis in 13 cases, the central vein
stenosis precluded fistula in the ipsilateral extremity in six
cases, the arterial inflow proximal to the brachial artery at
the antecubital fossa was inadequate in three cases, ade-
quate peripheral veins (not identified with duplex ultra-
sound scan) were identified in two cases, and suitable
arterial inflow (not identified with arterial pressure/wave-
forms) was identified in one case.
Native arteriovenous fistulae were performed in 90%
(125/139) of the patients for permanent hemodialysis
access (brachiobasilic, 39%; brachiocephalic, 36%; radioce-
phalic, 22%; radiobasilic, 3%). Arteriovenous fistulae were
constructed with prosthetic material (n 12) or superficial
femoral vein (n  2) in the remaining cases because of
inadequate peripheral veins (n  9), patient refusal of a
native fistula (n  2), morbid obesity (n  1), limited life
expectancy (n  1), and urgent need for permanent access
(n  1). Adjunctive procedures were performed concomi-
tantly with the native arteriovenous fistula in 7% and in-
cluded composite vein construction (n 8) and subclavian
artery angioplasty (n 1). The mean diameters of the vein
and the artery used for the native fistula creation were 3.3
0.7 mm and 3.9 1.1 mm, respectively. Flow through the
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native fistula was measured intraoperatively in 80% (100/
120), with a mean value of 509  283 mL/min. The flow
was less than 180 mL/min in 11%, 180 mL/min or more
and less than 300 mL/min in 13%, and 300 mL/min or
more in 76%.
The perioperative mortality rate (30 days) was 1%
(1/125) among the patients undergoing native arterio-
venous fistulae, and 20% of the patients had some type of
complication (Table II). Wound complications, including
both breakdown and hematoma, were the most common
complication and occurred in 10% of the patients. Hand
ischemia developed in 8% and was treated expectantly in
two cases and with some type of remedial procedure in the
remaining eight (fistula ligation, 2; inflow procedure, 2;
DRIL, 4). In addition, the bypass graft used for the DRIL
became stenotic during the early follow-up period and
necessitated revision in two cases. Four additional patients
died (cardiac, 2; CVA, 1; unknown, 1), and three were lost
to follow-up before fistula maturation or failure. The fistula
matured sufficiently to be used for cannulation in 84%
(98/117) of the patients with sufficient follow-up and was
suitable for cannulation in 3.4  1.8 months (Table III).
Fistula failure was caused by thrombosis in nine cases,
failure to dilate sufficiently in eight cases, and ligation in
two cases. Twenty-eight percent of the patients who re-
ceived native fistulae needed remedial invasive imaging, and
24% needed at least one remedial procedure (one proce-
dure, 22; two procedures, 6) for treatment of either a
complication or a delay in the fistula maturation. The
remedial procedures performed to facilitate fistula matura-
tion involved treatment of a stenosis within the central
veins (balloon angioplasty, 2) or fistula itself (interposition
graft, 10; resite anastomosis, 4; balloon angioplasty, 4; vein
patch angioplasty, 3). The native fistula matured suffi-
ciently for cannulation without any type of remedial imag-
ing or intervention in 63% of the patients with sufficient
follow-up. On the basis of an intention to treat approach, a
native fistula sufficient for cannulation developed in 71%
(98/139) of the patients for permanent hemodialysis ac-
cess. The multivariate analyses performed both including
and excluding the intraoperative flow measurement vari-
able similarly found that only female gender (odds ratio,
9.7; 95% CI, 2.2 to 43.5) and radiocephalic fistula config-
uration (odds ratio, 4.6; 95% CI, 1.1 to 18.6) were predic-
tive of fistula failure (odds ratio, 95% CI, excluding intra-
operative flow variable).
DISCUSSION
The results show that almost all patients presenting for
permanent hemodialysis access, including those with previ-
ous permanent accesses, are potential candidates for native
arteriovenous fistula with the aggressive algorithm. Indeed,
almost three possible configurations were identified per
patient with the noninvasive imaging. In addition, the
invasive imaging identified some type of abnormality in
approximately 40% of the cases and these findings impacted
the planned operative procedure almost 20% of the time.
Native arteriovenous fistulae were created in 90% of the
patients, and they matured sufficiently for cannulation in
approximately 85% of the cases with sufficient follow-up.
Some type of remedial imaging or remedial procedure was
necessary in approximately 25% of the cases. Regardless,
approximately 70% of the patients for permanent hemodi-
alysis access ultimately ended up with mature native fistula
sufficient for cannulation on the basis of an intention to
treat approach.
Our 90% rate for construction for native arteriovenous
fistulae is among the highest published and far exceeds the
50% target of the DOQI guidelines.1 Our success reflects a
strong commitment to an “all autogenous policy” and is
based on the bias that native arteriovenous fistulae are
superior to their prosthetic counterparts. Indeed, almost
every step of our algorithm was designed to optimize the
use of native arteriovenous fistulae. Specifically, we have
relied heavily on tunneled catheters as a bridge to allow
fistula maturation. We have exhausted all possible upper
extremity native fistula configurations before using pros-
thetic grafts, despite other algorithms, including the DOQI
guidelines, which advocate forearm prosthetic fistulae as
the third choice (radiocephalic  brachiocephalic  fore-
arm prosthetic). Furthermore, our approach has not been
bound by the usual access conventions that advocate pref-
erential use of the nondominant extremity and the forearm
first but rather attempts to select the fistula configuration
most likely to be successful. Our approach and bias are not
novel but are based on the standard principles and practice
of peripheral vascular surgery. The preoperative noninva-
sive/invasive imaging, vein marking, preference of autoge-
nous over prosthetic conduits, use of composite configura-
tions, and close postoperative follow-up with remedial
imaging/intervention detailed in this study all closely par-
Table II. Perioperative complications among patients
undergoing native arteriovenous fistulae
Access
configuration No.
Any
complication
Wound
complication
Hand ischemia
necessitating
Txp
Radiocephalic 28 11% 7% 0
Radiobasilic 3 0 0 0
Brachiocephalic 45 29% 9% 13%
Brachiobasilic 49 18% 12% 4%
Total 125 20% 10% 6%
Table III. Outcome among patients undergoing native
arteriovenous fistula with sufficient follow-up
Access
configuration No.
Mature
fistula
Remedial
procedure
Duration to
cannulation
(months)
Radiocephalic 28 75% 11% 3.7  2.1
Radiobasilic 3 100% 33% 3.7  2.9
Brachiocephalic 42 81% 33% 3.5  2.0
Brachiobasilic 44 91% 23% 3.3  1.4
Total 117 84% 24% 3.4  1.8
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allel our approach to infrainguinal revascularizations. In-
deed, we would contend that native hemodialysis arterio-
venous fistulae are comparable to “femoral-tibial” bypasses
in the upper extremity. It is no surprise that adequate
arterial inflow, adequate arterial/venous outflow, and an
adequate conduit usually translate to good long-term out-
come in both settings.
Our native fistula utilization rate and aggressive algo-
rithm are similar to the practice patterns of several other
groups committed to access surgery. Allon et al10 reported
that the introduction of a multidisciplinary approach in-
creased their rate of native fistula utilization from 32% to
69% and was associated with a decrease in the perioperative
complication rate. Ascher et al11 examined the impact of
the DOQI guidelines on their access practice and reported
a dramatic increase in the use of native fistulae (pre-DOQI,
5%; versus post-DOQI, 68%). Several groups have docu-
mented the value of preoperative noninvasive imaging be-
fore access construction.12-14 Indeed, the criteria used to
select the optimal artery/vein configuration for upper ex-
tremity access reported by Silva et al14 formed the basis or
our own criteria. It is interesting to note that although their
vein diameter criteria (2.5 mm versus 3.0 mm) were some-
what more liberal and they used the ulnar artery as an
alternative inflow site, a lower percentage of the patients
were candidates for native arteriovenous fistulae (63% ver-
sus 90%). The approach outlined by Miller et al9 to increase
the use of autogenous fistula included preoperative venog-
raphy and use of both brachiobasilic and brachiocephalic
configurations similar to our study. Surratt et al15 empha-
sized the importance of preoperative venography and re-
ported that 40% of all patients with prior subclavian vein
access catheters had significant central vein stenoses. Lastly,
Berman and Gentile16 documented the value of remedial
procedures and reported a 10% improvement in accom-
plishing or maintaining functional native fistulae.
The preoperative noninvasive and invasive imaging that
comprise major components of our algorithm appear to be
beneficial. The noninvasive imaging serves to outline the
possible fistula configurations, and the invasive imaging
serves to confirm the choice. Indeed, the number of abnor-
mal findings on the invasive imaging and their impact on
the operative plan were surprising, particularly in light of
the fact that the extremity imaged had been selected as the
one most optimal for fistula construction with the nonin-
vasive imaging. It is conceivable that the presence of occult
forearm arterial occlusive disease, the most common abnor-
mal finding on the invasive imaging, could contribute to
the reported inferior success rate of forearm fistula among
patients with diabetes, women, and the elderly.17,18 Admit-
tedly, the true value of the noninvasive/invasive imaging
cannot be assessed in our study because of the lack of the
proper control groups. Ideally, the utility of both imaging
methods should be tested in a randomized fashion, with the
control for the noninvasive imaging being either physical
examination alone or intraoperative exploration of the ves-
sels. It is unlikely that a comparable number of native fistula
configurations would be identified in these groups in light
of the fact that the basilic vein in the arm, which comprised
the leading configuration in our study, is almost impossible
to detect on physical examination alone because of its deep
anatomic course. Notably, Silva et al14 were able to increase
the rate of native arteriovenous fistulae in their practice
from 14% to 63% with the introduction of an imaging
protocol similar to ours. Furthermore, Mihmanli et al13
reported that the success rate for native arteriovenous fis-
tula was better in the patients randomized to preoperative
noninvasive imaging when compared with those who un-
derwent physical examination alone.
Despite our enthusiasm for the preoperative imaging,
both modalities are likely not necessary for every single
patient. The incremental benefit of the imaging studies in
young patients without systemic vascular disease, no prior
history of central venous cannulation, normal physical ex-
amination, and an easily identifiable forearm vein is likely
small. In addition, there is some risk and cost involved with
both the noninvasive and the invasive imaging. We have
attempted to minimize the contrast nephrotoxicity in the
patients before dialysis with gadolinium and carbon dioxide
as alternative agents and have obtained reasonable quality
images. The techniques to image the aortic arch and selec-
tively cannulate the subclavian artery place the patient at a
small risk for cerebral atheroembolization and stroke. Al-
though this complication did not occur during the study, a
patient of ours recently sustained a stroke during the pre-
access arteriogram, and it has forced us to be more circum-
spect about the role of the invasive imaging. We have not
actually looked at reimbursement for either preoperative
imaging method but suspect that it is probably poor. We
would contend that the incremental imaging costs likely
translate into improved outcome and access patency, al-
though it is unlikely that the various payers would concede
this point without solid data. It is notable that access
failures account for one of the leading causes of acute
hospitalization for patients with end stage renal disease19
and that each access failure costs the healthcare system an
estimated $4350 (1994 dollars).20
In conclusion, this study clearly shows that it is possible
to construct native arteriovenous fistulae in almost all pa-
tients for permanent dialysis access. This can be achieved
with an aggressive algorithm that parallels the general ap-
proach to infrainguinal revascularization. Preoperative
noninvasive and invasive imaging helps to both identify and
confirm the various possible fistula configurations, al-
though their roles merit further investigation with con-
trolled studies.
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DISCUSSION
Dr William A. Marston (Cary, NC). Thank you, Dr Broth-
ers. It has become increasing clear that our nephrology colleagues
armed with the DOQI guidelines and studies such as this one will
no longer accept surgeons who rely on the prosthetic AV graft as
their primary form of hemodialysis access. For those of us involved
in this area the question is not whether to construct AV fistulas but
how to adopt a protocol that will maximize their construction and
maturation into useful access sites.
Dr Huber and his colleagues at the University of Florida have
initiated an aggressive preoperative and postoperative protocol
that adapts techniques that have led to success in autogenous leg
revascularization. Specifically, they performed detailed noninvasive
imaging as well as both venography and arteriography in all pa-
tients to assist in decision making. The optimal configuration was
then selected, and careful postoperative follow-up was performed
with 22% of patients requiring remedial procedures to assist in
fistula maturation. The results were clearly outstanding: 90% of
patients received a fistula and 71% had one that matured to allow
successful hemodialysis. Although the manuscript raises numerous
questions and contains a wealth of information, I will limit my
questions to the following three.
First, AV fistulae are desirable for access primarily because
many will provide years of uncomplicated hemodialysis. To attain
higher rates of fistula construction, alternate types of fistulas other
than the radiocephalic or brachiocephalic are required, which may
not have as good patency rates over time. Do you know what the
prevalence of AV fistula use is in your population, and did you see
some of these alternate AV fistulas fail early after maturation
requiring other access procedures?
Secondly, in your series, 39% of your accesses were basilic vein
transpositions. This was performed in preference to a prosthetic access
in the forearm. Given that a forearm graft would not preclude later
basilic vein transposition, why not perform the prosthetic forearm
access first to maximize the potential time of access in each extremity?
And finally you reported that the aggressive preoperative
evaluation with venography and arteriography resulted in an al-
tered operative plan in 19% of cases. Will we be reimbursed for
performing these studies, and if not, are we able to select certain
patients that should undergo them?
I greatly enjoyed your presentation and thank the association
for allowing me to discuss it.
Dr Thomas S. Huber. Thank you for your insightful com-
ments. In response to your three questions, the first one regarding
the prevalence of AV fistula in our practice, we all started doing
access about 3 years ago based on the nephrologists’ dissatisfaction
with the surgeons that were doing it at our institution. At that
time, less than 30% of all the accesses were native arteriovenous
fistula. With the induction of our aggressive approach, and think-
ing about the problem like a distal bypass, we have increased that
rate in our practice to somewhere between 60% to 70%.
As far as the use of alternative or the basilic vein transposition,
our success rate for native fistulae is good because we have gone to
the forearm and then arm options preferentially over plastic.
Whether that is the right algorithm, I cannot tell you. The DOQI
recommendations go to the radiocephalic, brachiocephalic, and
then forearm plastic. Whether we are burning a bridge by going to
that brachiobasilic as our third choice, I am not certain. One would
argue that if you do a forearm plastic access you are preserving the
basilic vein, but I am not sure that is true. When a piece of forearm
plastic fails, it does not always fail just at the venous anastomosis; it
may fail in the outflow vein.
Reimbursement is a bit of a tricky issue. We are currently in the
process of going back through the last 200 noninvasive and inva-
sive imaging studies that we did to look at reimbursement. My
suspicion is that the reimbursement is poor. I would contend with
the payers that if we can construct better fistulas up front and our
patency rates are better, then it is likely cheaper in the long run.
The best I can tell you is that a 1-year patency rate for a piece of
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forearm plastic is about 45% and a 1-year patency rate for a native
fistula is about 65%, so there is a pretty significant difference.
Dr David Cull (Greenville, SC). We have adopted a similar
algorithm in trying to maximize AV fistula utilization. However, in
your algorithm, you have chosen to use the veins that exceed 3 mm
in size. That is a pretty big vein, and that probably is a large
explanation of your excellent results. Why did you chose that?
Most of the algorithms that have been developed have been
looking at pushing the envelope a little more in trying to further
maximize AV fistula utilization. We find a significant number of
patients in our population who have vein mapping that is a lot less
than 3 mm in diameter.
Dr Huber. Why do we choose it? It is based on our experi-
ence with lower extremity revascularization. A fairly large number
of studies have shown that for distal bypasses, 3-mm veins are good
and less than 3 mm is worrisome. Other people have pushed the
envelope for access and used 2-mm veins. I would agree that
perhaps our results are so good because we are using larger veins
relative to what other people reported, but we are still identifying
three possible fistula configurations per patient with those criteria
and our walking through the door success rate is 71%. I would just
say that it may not be the only way to approach this problem. There
are potentially even more aggressive ways to try to maximize your
native fistula, but this one seems to work with a reasonable criteria
and reasonable outcome.
Dr Robert Patterson (Providence, RI). Do you have any
tricks for initiating use of your autologous fistula? When you start
pushing the envelope—I have been trying to do it for years—I find
that the nephrologists read the DOQI guidelines and the nurses
and the techs that are accessing the fistulas do not. If they cannot
just find a great big pipe to put a needle in, they give it a try or
two, they get a hematoma, they have a problem, and then they
throw up their hands and complain. It becomes an issue. How
do you get them to start to allow these to mature a little more
safely?
Dr Huber. I do not have a magic answer for that one. As our
practice has evolved, we have pushed the envelope with the native
fistulae. There was a bit of a learning curve early on with the
technologists. We lost a few fistulae that I did not think we should
have lost, and I think the technologists have had to reeducate
themselves. I have no magic to tell them how to do it other than
that it is a little bit of trial and error. We are very careful about these
folks, and we see them on a monthly basis until we really feel the
fistula is usable and then only then turn them loose to the neph-
rologist. Our nephrologists are very good about going along with
our plan. We do have some troubles with the nephrologists in the
units that are out of our institution. They have elected to use these
fistulae a little bit earlier than I would have liked them to and we
have lost a few.
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